HLA-G and neoplasm: This findings highlighted the role of HLA-G in abrogating the in vivo CAR-NK cell anti-tumor activities and provides a rationale for therapeutic strategies using anti-HLA-G neutralizing Abs in combination with GD2 CAR-NK cells for patients with Ewing sarcoma [152].